Chemistree Completes Expansion of Sugarleaf Facility
Washington State operation grows by about 30% VANCOUVER, BC, Aug. 5, 2020 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (USOTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Washington State Liquor and Cannabis Board (“WSLCB”) has approved the Company’s expanded facility in Sedro Woolley for...Chemistree Closes First Tranche of ImmunoFlex Investment
Vancouver, British Columbia, July 9, 2020– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that, further to the news releases dated June 15th and 18th, 2020, the first tranche of the investment into Immuoflex Therapeutics (“ImmunoFlex”) has now closed. The definitive investment agreement includes Chemistree’s...Chemistree Details Immunoflex Investment
Cannabinoid-Linked, Immunology and Virology focused Biotech Venture VANCOUVER, BC, June 18, 2020 /CNW/ – Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), further to its announcement on June 15, 2020, the Company is pleased to introduce ImmunoFlex Therapeutics Inc....
Chemistree To Invest Up To $1 million In Cannabinoid-linked Biotech Venture
Vancouver, British Columbia, June 15, 2020– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a Binding Letter of...
CHEMISTREE PROVIDES WASHINGTON STATE AND GENERAL CORPORATE UPDATE
P.O. Box 10322, Pacific CentreSuite 810 – 609 Granville StreetVancouver, BC V7Y 1G5Tel: 604 678 8941 Fax: 604 689 7442 Vancouver, British Columbia, June 8, 2020– Chemistree...Chemistree Updates Strategic Review Initiatives – Grants Incentive Stock Options
Vancouver, British Columbia, April 9, 2020 – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), wishes to provide stakeholders with an update on the Company’s current investment portfolio and the recent launch of an internal strategic review. The Covid-19 pandemic is creating unprecedented challenges to the global economy and stock markets....Chemistree Provides Sugarleaf-Washington Update Covid-19 Response And Operations Update
Vancouver, British Columbia, April 2, 2020 – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), wishes to provide stakeholders with an update on the Company’s Washington State...
CHM – Where is the Next Level of Investor Coming From?
Jeremy Deichen (left) and Kirk Gamley (right) In this video, Jeremy Deichen interviews Kirk Gamely, investor relations consultant to Chemistree. They discuss the company and where the next level of cannabis investor will be coming from? To view the interview, click here to watch. For further information, connect with us at [email protected].
Chemistree Cancels PCCBD Investment
VANCOUVER, Oct. 7, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (USOTCQB: CHMJF) (the “Company” or “Chemistree”), announces that the proposed investment into The Physician’s Choice CBD (“PCCBD”) of Phoenix, Arizona, as previously announced in April 2019, has been terminated. Chemistree...